Ibritumomab Intravenous and Mifepristone Tablets (For Ending Early Pregnancy)
Determining the interaction of Ibritumomab Intravenous and Mifepristone Tablets (For Ending Early Pregnancy) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: mifepristone
Brand name: Korlym, Mifeprex
Synonyms: Mifepristone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Mifepristone Tablets (For High Blood Sugar)
- Ibritumomab Intravenous-Migalastat
- Ibritumomab Intravenous-Migalastat Hydrochloride
- Ibritumomab Intravenous-Migergot
- Ibritumomab Intravenous-Migergot Suppository
- Ibritumomab Intravenous-Miglitol
- Mifepristone Tablets (For Ending Early Pregnancy)-Ibritumomab Tiuxetan
- Mifepristone Tablets (For Ending Early Pregnancy)-Ibrutinib
- Mifepristone Tablets (For Ending Early Pregnancy)-Ibrutinib Capsules
- Mifepristone Tablets (For Ending Early Pregnancy)-Ibrutinib Tablets
- Mifepristone Tablets (For Ending Early Pregnancy)-Ibu
- Mifepristone Tablets (For Ending Early Pregnancy)-IBU Tablets